Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

[1]  H. Zetterberg,et al.  Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms , 2021, Journal of Infectious Diseases.

[2]  I. Koralnik,et al.  Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients , 2020, Annals of clinical and translational neurology.

[3]  M. Aepfelbacher,et al.  Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.

[4]  M. Dalakas,et al.  Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[5]  Ryan D. Chow,et al.  Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement , 2020, bioRxiv.

[6]  A. Al Madani,et al.  Cerebrospinal fluid confirmed COVID-19-associated encephalitis treated successfully , 2020, BMJ Case Reports.

[7]  B. Hemmer,et al.  Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms , 2020, Journal of the Neurological Sciences.

[8]  D. Pe’er,et al.  Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis , 2020, Science.

[9]  Á. Soriano,et al.  Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[10]  E. Robilotti,et al.  Determinants of COVID-19 disease severity in patients with cancer , 2020, Nature Medicine.

[11]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[12]  S. Farhadian,et al.  Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 , 2020, BMC Neurology.

[13]  Pardis C Sabeti,et al.  Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.

[14]  S. Castelain,et al.  COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF , 2020, Journal of Neurology.

[15]  B. Lina,et al.  Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic , 2020, The Lancet Microbe.

[16]  William T. Hu,et al.  Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020 , 2020, Emerging infectious diseases.

[17]  F. Neff,et al.  Early evidence of pronounced brain involvement in fatal COVID-19 outcomes , 2020, The Lancet.

[18]  Alokkumar Jha,et al.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.

[19]  R. Claus,et al.  Postmortem Examination of Patients With COVID-19. , 2020, JAMA.

[20]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[21]  Giacomo Garzaro,et al.  Smell and taste disorders during COVID‐19 outbreak: Cross‐sectional study on 355 patients , 2020, Head & neck.

[22]  Y. Huang,et al.  SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis , 2020, Brain, Behavior, and Immunity.

[23]  J. Sejvar,et al.  Neurological associations of COVID-19 , 2020, The Lancet Neurology.

[24]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[25]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[26]  Subha Ghosh,et al.  COVID-19 Autopsies, Oklahoma, USA , 2020, American journal of clinical pathology.

[27]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[28]  K. Blennow,et al.  Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. , 2019, JAMA neurology.

[29]  K. Rezvani,et al.  The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden. , 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[30]  S. Grupp,et al.  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  C. Turtle,et al.  Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies , 2018, CNS Drugs.

[32]  L. Deangelis,et al.  Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. , 2018, Cancer discovery.

[33]  C. Doglioni,et al.  Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells , 2018, Nature Medicine.

[34]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[35]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[36]  J. Kamińska,et al.  CXCL9 concentrations in cerebrospinal fluid and serum of patients with tick-borne encephalitis , 2016, Archives of medical science : AMS.

[37]  M. Iruretagoyena,et al.  Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation , 2015, Front. Immunol..

[38]  M. Brouwer,et al.  Corticosteroids for acute bacterial meningitis. , 2015, The Cochrane database of systematic reviews.

[39]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[40]  Zhi-jun Zhang,et al.  Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons , 2013, PAIN®.

[41]  G. Raymond,et al.  Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction , 2012, PloS one.

[42]  N. Zhong,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  D. Kolson,et al.  Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.

[44]  M Rappaport,et al.  Disability rating scale for severe head trauma: coma to community. , 1982, Archives of physical medicine and rehabilitation.

[45]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.